BIO CEO & Investor Conference

Biotechnology Industry Organization - BIO

Event Info

  • Date:

    2.12.2013

  • Time:

    1:30 pm - 2:30 pm EST

  • Location:

    New York, NY

Topics

  • The Road Less Traveled: Alternative Avenues to Public Markets
    (William C. Hicks, Moderator )

In hopes of avoiding the expense, uncertainty, and complexity of the IPO process, an increasing number of companies are foregoing the IPO route and using alternative means to the public markets including reverse mergers, Form-10 self-filings, and variations of each.  Hear from experienced professionals who have traveled these new routes discuss lessons learned, deal structures, and how recent legislation like the JOBS Act could affect public exits.

Moderator:

William Hicks, Member, Mintz Levin    

  • Panelists:

    Charles Crain, Manager, Policy & Research, BIO

    Michelle Dipp, MD, PhD, Chief Executive Officer & Co-Founder, OvaScience

    Daniel B. Dubin, MD, Vice Chairman, Chief Knowledge Officer & Founder of MEDACorp, Leerink Swann

    Peter Kolchinsky, PhD, Managing Partner, RA Capital